(Total Views: 719)
Posted On: 03/18/2025 10:16:51 AM
Post# of 156040
I’d say we are hands off for now. Maybe a partner way down the road but I think they shifted focus, maybe why no MASH TAG. It’s done on our end. Fat on the liver is the start of MASH. I don’t think we can treat MASH on our own. Ohm can you chime in please. I’m curious as well.
Pivot to fibrous of other organs or maybe MASH set is set aside for now until someone wants to take the risk to fund it. MASH is such a big undertaking. I think we hit the pause button until someone else wants to take it on. That’s how I read it.
Pivot to fibrous of other organs or maybe MASH set is set aside for now until someone wants to take the risk to fund it. MASH is such a big undertaking. I think we hit the pause button until someone else wants to take it on. That’s how I read it.


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com